Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Anna Vickers"'
Aztreonam/avibactam is being developed on the rationale that aztreonam evades metallo-β-lactamases (MBLs) whilst avibactam protects aztreonam against co-produced serine β-lactamases. This study measured the activity of aztreonam/avibactam against M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf38a0725e5c2d961585330d6b519a3
https://ueaeprints.uea.ac.uk/id/eprint/91357/
https://ueaeprints.uea.ac.uk/id/eprint/91357/
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:1916-1922
Objectives Combinations of PBP3-active β-lactams with developmental diazabicyclooctanes (DBOs), e.g. zidebactam, remain active against many MBL producers via an enhancer effect. We explored how this activity is affected by inoculum. Materials and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06094fed32d060f6572af2251ee1f136
https://doi.org/10.1093/jac/dkac108
https://doi.org/10.1093/jac/dkac108
Publikováno v:
Journal of Infection and Public Health, Vol 8, Iss 1, Pp 90-97 (2015)
Summary: Asymptomatic carriage of methicillin-resistant Staphylococcus aureus (MRSA) can predispose the host to a wide range of infections. To inform public health strategies, this study sought to determine the prevalence and the phenotypic and genot
Externí odkaz:
https://doaj.org/article/099c90fb13a8464ba4e308d086dd61e5
Background Secondary healthcare will remain pressured for some years, both because SARS-CoV-2 will circulate as a nosocomial pathogen, and owing to backlogs of patients awaiting delayed elective procedures. These stresses will drive the use of Outpat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8134e23f4a434dd79571b7da89a14f8b
https://ueaeprints.uea.ac.uk/id/eprint/87067/
https://ueaeprints.uea.ac.uk/id/eprint/87067/
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:434-442
Background ESBL- and carbapenemase-producing Pseudomonas aeruginosa are prevalent in, for example, the Middle East, Eastern Europe and Latin America, though rarer elsewhere. Because P. aeruginosa readily mutate to become carbapenem resistant via loss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83c2f8a0307e46d547f97b86369d9e52
https://doi.org/10.1093/jac/dkaa456
https://doi.org/10.1093/jac/dkaa456
Autor:
Michel Doumith, David M. Livermore, Shazad Mushtaq, Anna Vickers, Neil Woodford, Matthew J. Ellington
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:160-170
BackgroundBoronates are of growing interest as β-lactamase inhibitors. The only marketed analogue, vaborbactam, principally targets KPC carbapenemases, but taniborbactam (VNRX-5133, Venatorx) has a broader spectrum.MethodsMICs of cefepime and merope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3e5aadbd509ddef2bc6015ab3a56c6
https://doi.org/10.1093/jac/dkaa391
https://doi.org/10.1093/jac/dkaa391
Autor:
Shamez N. Ladhani, Sarah Collins, Anna Vickers, David J. Litt, Carina Crawford, Mary E. Ramsay, Mary P.E. Slack
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 5, Pp 725-732 (2012)
Haemophilus influenzae infection causes serious invasive disease, but incidence of the most virulent serotype, Hib, has dropped since introduction of routine Hib vaccination. In England and Wales, the incidence of 2 other serotypes, Hie and Hif, is i
Externí odkaz:
https://doaj.org/article/7d2b0aa11e4b4c738f9b827f8fd978d3
Autor:
Vickers, Anna
Expresses gratitude for the paper, Die Lithothamnien des Adriatischen Meeres und Marokkos. Information about the work on the algae of Barbados.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d056b90e9eec201839602953bb89b11a
Publikováno v:
The Journal of antimicrobial chemotherapy. 77(1)
Background Aztreonam/avibactam is being developed for its broad activity against carbapenemase-producing Enterobacterales, including those with metallo-β-lactamases (MBLs). Its potential to select resistance in target pathogens was explored. Finding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba02d26c22bce2bf0a8dd739ffeafd41
https://pubmed.ncbi.nlm.nih.gov/34568905
https://pubmed.ncbi.nlm.nih.gov/34568905
Publikováno v:
The Journal of antimicrobial chemotherapy. 76(6)
Background Triple-action diazabicyclooctanes, e.g. zidebactam, combine β-lactamase inhibition, antibacterial activity, and ‘enhancement’ of PBP3-targeted β-lactams. Objectives To examine the activity of cefepime/zidebactam against consecutive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01c20ffcbeb68be960b0c7bc62212db7
https://pubmed.ncbi.nlm.nih.gov/33760082
https://pubmed.ncbi.nlm.nih.gov/33760082